Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
Rhea-AI Summary
Iridex (Nasdaq: IRIX) will present at the Planet MicroCap Las Vegas 2026 Conference. Management is scheduled to present on Wednesday, June 17, 2026 at 4:00 pm PT.
A live and archived webcast will be available via the Event Calendar in the Investors section of the company website.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
IRIX slipped 0.45% while sector peers were mixed: TRIB up 0.29%, ADGM down 6.24%, NSYS down 3.32%, PTHL up 113.16%, VVOS down 4.81%. Momentum scans only flagged MYO, down slightly, reinforcing a stock-specific backdrop to this conference update.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| May 19 | Q1 2026 earnings | Neutral | -4.8% | Flat revenue with margin pressure but narrowed net loss and reaffirmed guidance. |
| May 05 | Earnings date set | Neutral | -0.9% | Announcement of Q1 2026 release date and conference call logistics. |
| Apr 07 | Commercial partnership | Positive | +0.0% | New EyeProGPO partnership to expand access to retina laser technology. |
| Mar 26 | Q4/FY 2025 earnings | Positive | -26.7% | Double-digit Q4 growth, FY 2025 revenue up and adjusted EBITDA turning positive. |
| Mar 12 | Earnings date set | Neutral | -2.3% | Scheduling of Q4 and full-year 2025 results and accompanying conference call. |
Recent earnings and scheduling announcements often saw flat-to-negative price reactions, even when fundamentals or guidance showed improvements.
Over the last few months, IRIDEX has focused on financial execution and commercial expansion. Q4 2025 and Q1 2026 results showed revenue around $52.7M for 2025 and Q1 revenue of $11.8M, with improved net loss and positive adjusted EBITDA, yet shares fell after both earnings on Mar 26 and May 19. A new EyeProGPO partnership on Apr 7 aimed to broaden retina laser access but produced no immediate price reaction. Today’s conference appearance fits a pattern of ongoing investor outreach alongside operational tightening and guidance reaffirmation.
Market Pulse Summary
This announcement highlights IRIDEX’s participation in the Planet MicroCap Las Vegas 2026 Conference, with management presenting on June 17 at 4:00 pm PT. It follows recent quarterly filings that showed improved losses and reaffirmed guidance, as well as active insider buying. Investors tracking the story may focus on any new qualitative commentary from the presentation, especially around growth initiatives, margin trajectory, and commercial partnerships noted in prior updates.
AI-generated analysis. Not financial advice.
MOUNTAIN VIEW, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced plans to participate in the upcoming Planet MicroCap Las Vegas 2026 Conference.
Management is scheduled to present on Wednesday, June 17 at 4:00 pm PT. Interested parties may access a live and archived webcast of the presentation on the “Event Calendar” page of the “Investors” section of the company’s website at www.IRIDEX.com.
About Iridex Corporation
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated laser treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. Iridex products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the Iridex website at www.iridex.com.
MicroPulse® is a registered trademark of Iridex Corporation, Inc. in the United States, Europe and other jurisdictions. © 2026 Iridex Corporation. All rights reserved.
Investor Relations Contact
Philip Taylor
Gilmartin Group
investors@iridex.com
Media Contact
Joan Stauffer
jstauffer@iridex.com
